Collagen Diseases  >>  fosdagrocorat (PF-04171327)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fosdagrocorat (PF-04171327) / Pfizer
NCT00938587 / 2009-013223-37: A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis

Completed
2
86
Europe, US, RoW
PF-04171327 10 mg, Prednisone Placebo, PF-04171327 25 mg, Prednisone 5 mg, Placebo for PF-04171327, Placebo
Pfizer
Rheumatoid Arthritis
07/10
07/10
NCT01393639 / 2010-023782-22: Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis

Completed
2
323
US, Europe, RoW
PF-04171327, prednisone, placebo
Pfizer
Rheumatoid Arthritis
06/14
06/14

Download Options